A Clinician’s Perspective: Gene Therapy for X-Linked Myotubular Myopathy

Time: 8:45 am

Details:

• -X-Linked Myotubular Myopathy (XLMTM): Burden of disease
• Gene therapy and efficacy outcomes
• Safety profile and liver toxicity